APA (7th ed.) Citation

Balcer, O. M., Seager, M. A., Gleason, S. D., Li, X., Rasmussen, K., Maxwell, J. K., . . . Witkin, J. M. (2019). Evaluation of 5-HT7 receptor antagonism for the treatment of anxiety, depression, and schizophrenia through the use of receptor-deficient mice. Behavioural brain research, 360, 270-278. https://doi.org/10.1016/j.bbr.2018.12.019

Chicago Style (17th ed.) Citation

Balcer, Olivia M., Matthew A. Seager, Scott D. Gleason, Xia Li, Kurt Rasmussen, Julia K. Maxwell, George Nomikos, Aldemar Degroot, and Jeffrey M. Witkin. "Evaluation of 5-HT7 Receptor Antagonism for the Treatment of Anxiety, Depression, and Schizophrenia Through the Use of Receptor-deficient Mice." Behavioural Brain Research 360 (2019): 270-278. https://doi.org/10.1016/j.bbr.2018.12.019.

MLA (9th ed.) Citation

Balcer, Olivia M., et al. "Evaluation of 5-HT7 Receptor Antagonism for the Treatment of Anxiety, Depression, and Schizophrenia Through the Use of Receptor-deficient Mice." Behavioural Brain Research, vol. 360, 2019, pp. 270-278, https://doi.org/10.1016/j.bbr.2018.12.019.